–
Voyager Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−73.6
FY22:
−50.8
FY23:
122
FY24:
−83.3
FY25:
−132
(positive)
Change from FY21 to FY25
millions USD
FY21:
−68.5
FY22:
−44.6
FY23:
126
FY24:
−78.6
FY25:
−128
(positive)
Change from FY21 to FY25
millions USD
FY21:
−71.2
FY22:
−46.4
FY23:
134
FY24:
−64.3
FY25:
−120
(positive)
Change from FY21 to FY25
millions USD
FY21:
−71.2
FY22:
−46.4
FY23:
132
FY24:
−65.0
FY25:
−120
All amounts in millions USD